Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study
Completed · Not applicable · Has a placebo group
Conditions studied: Blood Sugar; High, Overweight and Obesity, Fat Loss, GLP-1, Glucagon
In brief
BACKGROUND GLP1 booster (GB) was designed to stimulate the endogenous production of GLP1, which in turn releases insulin, controls blood glucose level, suppresses appetite and thus helps people lose weight. PURPOSE In prior study, GB was clinically shown to reduce blood sugar level, increase GLP-1 production, and help body fat loss. The purpose of this RCT study is to further assess several clinical endpoints and questionnaires in healthy volunteers taking the new GB formula vs placebo, in the hope of confirming the efficacy and safety of GB. SCOPE The scope of this protocol covers the non-clinical portion as well as the assessment of several clinical endpoints and questionnaires. In brief, this study is a randomized controlled clinical trial for a total of 26 weeks. Data analysis will involve measuring the clinical endpoints across the group at different timepoints (week 0, 13 and 26).
Key facts
- Study ID
- NCT07141472
- Run by
- Lawry Han
- People needed
- 69
- Starts
- 2025-01-07
- Expected to finish
- 2025-08-14
- Last updated by the study team
- 2025-09-03
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Volunteers must be over the age of 18.
- Volunteers cannot be smokers.
- Volunteers cannot be currently taking a dietary supplement or prescription for weight loss.
- Exercising volunteers must maintain their regimen consistently throughout the course of the 26-week study.
- Caffeine drinking volunteers must maintain their caffeine intake consistently throughout the course of the 26-week study.
- Volunteers need to be overweight but not obese, as defined by having a BMI between 25.0 and 29.9
Where it is running
- Alpine Bio — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.